Events

MSACL 2025 - Annual Conference and Exhibits

Mass Spectometry and Advances in Clinical Lab Conference & Exhibits - 2025
Roche Diagnostics at MSACL Conference & Exhibits 2025

Our workshop will highlight a major innovation in laboratory medicine while exploring the increasing use of mass spectrometry in clinical diagnostics as a complement to traditional chemistry and immunochemistry techniques.

The cobas® Mass Spec solution a fully automated LC-MS/MS analyzer that integrates sample extraction and parallel testing using liquid chromatography cartridges - enabling random access testing at higher throughput compared to traditional LC-MS implementations.

This event is a valuable opportunity for laboratory professionals and clinicians to gain insights into the strengths and challenges of a fully automated LC-MS/MS analyzer.
 

*cobas® pro i 601 analyzer and Ionify reagents (iST1, iST2, iVD1, iISD, and iAED2 reagent packs) are available for sale in countries accepting the CE-Mark. Additional Ionify reagents are in development. In the USA, these products are in development, not cleared or approved by FDA, and not available for sale.

MSACL Roche Industry Workshop

Tuesday, September 23 | 12:45 - 2 p.m.
Location: Salle de Bal de Montreal 4

An overview of the cobas® Mass Spec solution

Dr. M. Laura Parnas, Roche Diagnostics, Indianapolis, IN, USA
 

The impact of standardization and traceability on Ionify® reagents

Dr. Elie Fux, Roche Diagnostics, Penzberg, Germany
 

The Future of Mass Spectrometry - Insights into a fully automated and integrated mass spec solution

Dr. William Clarke, Johns Hopkins University, Baltimore, MD, USA

Dr. Russell Grant, Labcorp, Burlington, NC, USA

Dr. Raymond Suhandynata, UC San Diego, San Diego, CA, USA

Prof. Dr. Michael Vogeser, Ludwig Maximilian University, Munich, Germany